Please login to the form below

Not currently logged in
Email:
Password:

Immunocore appoints chief financial officer

Paul Fry brings leadership experience from GlaxoSmithKline

Oxford, UK-based Immunocore has appointed Paul Fry as its chief financial officer.

Fry has over two decades of senior management experience in the life sciences and telecommunications industries and joins the biotech from Vodafone, where he served as director of global finance operations.

Prior to this, Fry spent 25 years at GlaxoSmithKline, during which time he held a number of senior roles including head of global financial services and chief financial officer for the pharmaceutical company's Italian business.

In his most recent role there, Fry oversaw all the financial aspects of the exchange of GSK's oncology business for Novartis Vaccines.

Dr Eliot Forster, chief executive officer of Immunocore, said: “I am delighted that Immunocore has been able to recruit someone of the calibre of Paul Fry, who will provide leadership across our financial operations as we continue our mission to become a world leader in biotechnology.

“As Immunocore continues to grow we are continually looking for outstanding individuals such as Paul to complement our team. He joins at an exciting time for the company and we very much look forward to working with him.”

21st October 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics